TALKING HEADS: A service that fills the follow-up gap

As World AIDS Day on Thursday approaches, Kim Hoepfl looks at an NGO that helps keep HIV-positive workers productive.

More information

Biohealthcluster / ABL-DeepChek™

"ABL DeepChek™ Using High-Throughput Sequencing Systems Aids in the Generation of Clinically Meaningful Genotyping Reports for Personalized Healthcare". See the presentationhttp://www.biohealthcluster.lu/News/ABL-DeepChekTM

---

TherapyEdge® Chronic Care Management

Click here to receive the product sheet by email

Agreement with CIDRZ

ABL is pleased to announce the agreement with CIDRZ (Centre for Infectious Diseases Research in Zambia) for the use of ViroScore® Suite at their facilities for the management of the HIV sequences. The TherapyEdge® clinical software is part of the agreement for the clinical documentation of HIV drug resistance data. More details to come soon. More about CIDRZ

South African Patent

ABL is pleased to report the South African Patent Office has been issued patent N° 2009/07533 and has been granted for 20 years from the filing date, April 10, 2008. This patent is related to the Emory Patent Internal Application WO/2008/124192. Link to the issued patent

Luciano et al. patent 6,063,028 et patent 6,317,731

ABL is pleased to announce the acquisition and ownership of 2 US patents (Luciano - 6,063,028 and Luciano - 6,317,731) having as main inventor Dr Joanne Luciano.

Barry et al. patent 6,081,786 et patent 6,188,988

ABL is very pleased to report that a notice of allowance (2009 - 188754) has been issued by the Japanese Patent Office for the ABL patent “Systems, methods, and computer program products for guiding the selection of therapeutic treatment regimens”. This patent is related to the ABL US Patents 6,081,786 and 6,188,988 from Barry et al. See the allowance ABL has also received 2 new certificates following the re-examination requests for ABL US Patents 6,081,786 and 6,188,988. No claims were invalidated or amended for both patents. New 6081786 patent certificate, New_6188988_patent_certificate

International Workshop on HIV&HEPATITIS VIRUS

ABL is pleased to announce an abstract and poster presented at the International Workshop on HIV & Hepatitis Virus Drug Resistance and Curative Strategies (Los Cabos, Baja California Sur, Mexico, June 7-11, 2011).

The poster "A Fully Integrated and Simplified HIV Clinical Genotyping Solution Using 454 Ultra-Deep-Sequencing and the DeepChek™-HIV system" was presented by Dr Roger Parades behalf on the PRIUS study team. Click here to receive the poster by email

Comments of PRIUS-I study : http://www.aidsbeacon.com/news/2011/06/17/better-assessment-of-drug-resistance-may-improve-treatment-of-people-with-hiv-aids/

TherapyEdge® Launches the HIV eRegister for Windows

Click here to receive the product sheet by email